Upcoming Webinars

Strategic approaches for early clinical trials in neurodegenerative diseases

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • October 14, 2026 | 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central)
  • 60 min

Upcoming Webinars

Building Fit-for-Purpose Oncology Real-World Evidence in Japan

Biotech, Commercialization & HEOR, Drug Discovery & Development, Emerging Market, Life Science, Pharma,
  • October 15, 2026 | 4pm JST (Japan) / 3am EDT (NA) / 8am BST (UK) / 9am CET (EU-Central)
  • 60 min

Upcoming Webinars

Beyond the Surface: Navigating Endpoint Complexity & Safety in Dermatology Clinical Trials

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Patient Safety, Pharma,
  • October 15, 2026 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
  • 60 min

Upcoming Webinars

Expanding Cell & Gene Therapy Access Requires More Than Science (Broadcast 1)

Biotech, Cell and Gene Therapy, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • October 15, 2026 | 1pm EDT / 12pm CDT / 10am PDT
  • 60 min

Upcoming Webinars

Expanding Cell & Gene Therapy Access Requires More Than Science (Broadcast 2)

Biotech, Cell and Gene Therapy, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • October 16, 2026 | 3pm EDT / 2pm CDT / 12pm PDT
  • 60 min

Upcoming Webinars

October 14, 2026

Strategic approaches for early clinical trials in neurodegenerative diseases
Hero - Desktop
October 15, 2026

Building Fit-for-Purpose Oncology Real-World Evidence in Japan
Hero - Desktop
October 15, 2026

Beyond the Surface: Navigating Endpoint Complexity & Safety in Dermatology Clinical Trials
Hero - Desktop
October 15, 2026

Expanding Cell & Gene Therapy Access Requires More Than Science (Broadcast 1)
Hero - Desktop
October 16, 2026

Expanding Cell & Gene Therapy Access Requires More Than Science (Broadcast 2)
Hero - Desktop
October 19, 2026

Inflammation as a Clinical Endpoint in CKM: Are We There Yet?
Hero - Desktop
October 20, 2026

Reduce Cell Bank Manufacturing Risk and Accelerate Characterization
Hero - Desktop
October 20, 2026

Inside Regeneron's Path to Scientific Intelligence and R&D Efficiency
Hero - Desktop
October 21, 2026

Beyond the Protocol: Advancing Patient- and Caregiver-Centered Approaches in Neurodegenerative Clinical Trials
Hero - Desktop
October 21, 2026

Keeping clinical trial patients enrolled: real stories of high-touch support
Hero - Desktop
October 22, 2026

Accelerate Participant Matching with Precision Recruitment
Hero - Desktop
October 22, 2026

Executing Successful Psychedelic Studies from Protocol to Patient
Hero - Desktop
October 22, 2026

Formulate Pet Health Products to Improve Aging, Mobility and Immunity
Hero - Desktop
October 23, 2026

Why CVOTs Require a Different Approach: Optimizing Event Accrual to Reduce Trial Delays
Hero - Desktop
October 26, 2026

Manufacturing Bispecific Antibodies: Development & Scale-Up
Hero - Desktop
October 27, 2026

The Last Human Mile in Medical Information: Scaling Biotech Launch Support
Hero - Desktop